Diluge 发表于 2025-3-26 22:57:20

http://reply.papertrans.cn/67/6641/664098/664098_31.png

口诀法 发表于 2025-3-27 03:41:03

http://reply.papertrans.cn/67/6641/664098/664098_32.png

Decibel 发表于 2025-3-27 07:57:35

http://reply.papertrans.cn/67/6641/664098/664098_33.png

修剪过的树篱 发表于 2025-3-27 12:19:18

http://reply.papertrans.cn/67/6641/664098/664098_34.png

使更活跃 发表于 2025-3-27 15:27:34

http://reply.papertrans.cn/67/6641/664098/664098_35.png

Entirety 发表于 2025-3-27 18:09:46

Multiple Sclerosis: Diagnosis and Treatmentfingolimod and intravenous natalizumab are second line, even though they are more effective, because the long-term safety profiles remain unknown. To achieve disease activity-free status (DAFS), which includes the combination of no clinically apparent relapses, no new MRI activity, and no progressio

灯泡 发表于 2025-3-28 00:58:39

http://reply.papertrans.cn/67/6641/664098/664098_37.png

GEST 发表于 2025-3-28 05:07:14

Autoantibodies in Guillain-Barré Syndrome (GBS)tions of antiglycolipid antibodies are regulated by the antibody avidity, which is influenced by (1) the specific distribution of target glycolipids in the PNS, (2) the glycolipid environment surrounding target antigens, (3) the amount of targeted glycolipids in specific regions, (4) the steric micr

Complement 发表于 2025-3-28 09:36:17

http://reply.papertrans.cn/67/6641/664098/664098_39.png

收到 发表于 2025-3-28 10:33:32

http://reply.papertrans.cn/67/6641/664098/664098_40.png
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: Neuroimmunological Diseases; Susumu Kusunoki Book 2016 Springer Japan 2016 Guillain-Barré Syndrome.Multiple Sclerosis.Neuroimmunology.Neur